make a note on pharmacology and classification of antifungals in short amphotericin b in details and role of antifungals In ent in detail for essay answer of ent pg exam and make it into pdf
mkdir -p /home/daytona/workspace/antifungals-ent
~/antifungals-ent/generate_pdf.py
from reportlab.lib.pagesizes import A4
from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle
from reportlab.lib.units import cm, mm
from reportlab.lib import colors
from reportlab.platypus import (
SimpleDocTemplate, Paragraph, Spacer, Table, TableStyle,
HRFlowable, KeepTogether, PageBreak
)
from reportlab.lib.enums import TA_LEFT, TA_CENTER, TA_JUSTIFY
from reportlab.platypus import BaseDocTemplate, Frame, PageTemplate
OUTPUT = "/home/daytona/workspace/antifungals-ent/Antifungals_ENT_PG_Essay.pdf"
# ── colour palette ────────────────────────────────────────────────────────────
NAVY = colors.HexColor("#1a3a5c")
TEAL = colors.HexColor("#1a7a7a")
GOLD = colors.HexColor("#c8860a")
LTBLUE = colors.HexColor("#e8f2f8")
LTGOLD = colors.HexColor("#fdf5e4")
WHITE = colors.white
DARK = colors.HexColor("#1c1c1c")
MGRAY = colors.HexColor("#555555")
LGRAY = colors.HexColor("#dddddd")
# ── styles ────────────────────────────────────────────────────────────────────
styles = getSampleStyleSheet()
def S(name, **kw):
return ParagraphStyle(name, **kw)
TITLE = S("MyTitle",
fontSize=22, leading=28, textColor=WHITE,
fontName="Helvetica-Bold", alignment=TA_CENTER, spaceAfter=4)
SUBTITLE = S("MySubtitle",
fontSize=12, leading=16, textColor=LTBLUE,
fontName="Helvetica", alignment=TA_CENTER, spaceAfter=2)
H1 = S("H1",
fontSize=14, leading=18, textColor=WHITE,
fontName="Helvetica-Bold", alignment=TA_LEFT,
spaceBefore=14, spaceAfter=6)
H2 = S("H2",
fontSize=12, leading=16, textColor=NAVY,
fontName="Helvetica-Bold", alignment=TA_LEFT,
spaceBefore=10, spaceAfter=4)
H3 = S("H3",
fontSize=11, leading=14, textColor=TEAL,
fontName="Helvetica-Bold", alignment=TA_LEFT,
spaceBefore=8, spaceAfter=3)
BODY = S("MyBody",
fontSize=10, leading=15, textColor=DARK,
fontName="Helvetica", alignment=TA_JUSTIFY,
spaceBefore=3, spaceAfter=3)
BULLET = S("MyBullet",
fontSize=10, leading=14, textColor=DARK,
fontName="Helvetica", leftIndent=16, bulletIndent=4,
alignment=TA_JUSTIFY, spaceBefore=2, spaceAfter=2)
SUBBULLET = S("SubBullet",
fontSize=10, leading=13, textColor=MGRAY,
fontName="Helvetica", leftIndent=30, bulletIndent=18,
alignment=TA_JUSTIFY, spaceBefore=1, spaceAfter=1)
KEY = S("Key",
fontSize=9.5, leading=13, textColor=DARK,
fontName="Helvetica", alignment=TA_JUSTIFY,
leftIndent=6, spaceBefore=2, spaceAfter=2)
TABLE_HEADER = S("TH",
fontSize=9.5, leading=12, textColor=WHITE,
fontName="Helvetica-Bold", alignment=TA_CENTER)
TABLE_CELL = S("TC",
fontSize=9, leading=12, textColor=DARK,
fontName="Helvetica", alignment=TA_LEFT)
TABLE_CELL_C = S("TCC",
fontSize=9, leading=12, textColor=DARK,
fontName="Helvetica", alignment=TA_CENTER)
NOTE = S("Note",
fontSize=9, leading=12, textColor=MGRAY,
fontName="Helvetica-Oblique", alignment=TA_LEFT,
leftIndent=10, spaceBefore=3, spaceAfter=5)
# ── helpers ────────────────────────────────────────────────────────────────────
def h1_block(text):
"""Navy banner heading."""
return Table(
[[Paragraph(text, H1)]],
colWidths=[17*cm],
style=TableStyle([
("BACKGROUND", (0,0), (-1,-1), NAVY),
("TOPPADDING", (0,0), (-1,-1), 7),
("BOTTOMPADDING", (0,0), (-1,-1), 7),
("LEFTPADDING", (0,0), (-1,-1), 12),
("RIGHTPADDING", (0,0), (-1,-1), 8),
("ROUNDEDCORNERS",(0,0), (-1,-1), [4,4,4,4]),
])
)
def h2_block(text):
return Table(
[[Paragraph(text, H2)]],
colWidths=[17*cm],
style=TableStyle([
("BACKGROUND", (0,0), (-1,-1), LTBLUE),
("TOPPADDING", (0,0), (-1,-1), 5),
("BOTTOMPADDING", (0,0), (-1,-1), 5),
("LEFTPADDING", (0,0), (-1,-1), 10),
("LINEBELOW", (0,0), (-1,-1), 1.2, TEAL),
])
)
def gold_box(text):
return Table(
[[Paragraph(text, KEY)]],
colWidths=[17*cm],
style=TableStyle([
("BACKGROUND", (0,0), (-1,-1), LTGOLD),
("TOPPADDING", (0,0), (-1,-1), 6),
("BOTTOMPADDING", (0,0), (-1,-1), 6),
("LEFTPADDING", (0,0), (-1,-1), 12),
("RIGHTPADDING", (0,0), (-1,-1), 8),
("BOX", (0,0), (-1,-1), 1, GOLD),
])
)
def bullet(text, level=1):
if level == 1:
return Paragraph(f"• {text}", BULLET)
else:
return Paragraph(f"◦ {text}", SUBBULLET)
def sp(h=6):
return Spacer(1, h)
def hr():
return HRFlowable(width="100%", thickness=0.5, color=LGRAY, spaceAfter=4, spaceBefore=4)
# ── cover page helper ──────────────────────────────────────────────────────────
def cover_page():
"""Returns a list of flowables making up the cover."""
cover = Table(
[[Paragraph("PHARMACOLOGY & CLINICAL ROLE OF", SUBTITLE),
Paragraph("ANTIFUNGAL AGENTS IN ENT", TITLE),
Paragraph("Comprehensive Essay for PG Entrance Examination", SUBTITLE),
Spacer(1, 6),
Paragraph("Includes: Classification · Amphotericin B (Detailed) · Role of Antifungals in ENT", NOTE)]],
colWidths=[17*cm],
style=TableStyle([
("BACKGROUND", (0,0), (-1,-1), NAVY),
("TOPPADDING", (0,0), (-1,-1), 30),
("BOTTOMPADDING", (0,0), (-1,-1), 30),
("LEFTPADDING", (0,0), (-1,-1), 20),
("RIGHTPADDING", (0,0), (-1,-1), 20),
])
)
return [cover, sp(14)]
# ══════════════════════════════════════════════════════════════════════════════
# DOCUMENT BUILD
# ══════════════════════════════════════════════════════════════════════════════
def build():
doc = SimpleDocTemplate(
OUTPUT,
pagesize=A4,
leftMargin=2*cm, rightMargin=2*cm,
topMargin=2*cm, bottomMargin=2*cm,
title="Antifungals – Pharmacology & Role in ENT",
author="Orris Medical Notes"
)
story = []
# ── COVER ─────────────────────────────────────────────────────────────────
story += cover_page()
# ══════════════════════════════════════════════════════════════════════════
# SECTION 1 – INTRODUCTION
# ══════════════════════════════════════════════════════════════════════════
story.append(h1_block("1. INTRODUCTION"))
story.append(sp(6))
story.append(Paragraph(
"Fungal infections have increased dramatically in incidence and severity, "
"mainly due to advances in surgery, cancer treatment, organ/bone marrow "
"transplantation, the HIV epidemic, and widespread use of broad-spectrum "
"antibiotics in critically ill patients. Fungi are eukaryotes, making targeted "
"pharmacotherapy challenging — differences in sterol biosynthesis, cytosine "
"deamination ability, and unique cell wall components (glucans, chitin) have "
"been exploited to develop antifungal agents with relative selectivity.",
BODY))
story.append(sp(4))
story.append(Paragraph(
"For many years, <b>Amphotericin B</b> was the only efficacious agent for systemic "
"use. The introduction of azoles and echinocandins revolutionised therapy. "
"Despite this, mortality from invasive fungal disease remains unacceptably high.",
BODY))
story.append(sp(10))
# ══════════════════════════════════════════════════════════════════════════
# SECTION 2 – CLASSIFICATION
# ══════════════════════════════════════════════════════════════════════════
story.append(h1_block("2. CLASSIFICATION OF ANTIFUNGAL AGENTS"))
story.append(sp(6))
story.append(gold_box(
"<b>Mnemonic:</b> <i>Poly-Azole-Echino-Allyl-Misc</i> — "
"Polyenes | Azoles | Echinocandins | Allylamines | Miscellaneous"
))
story.append(sp(8))
# ── Classification table ──────────────────────────────────────────────────
class_data = [
[Paragraph("Class", TABLE_HEADER),
Paragraph("Mechanism", TABLE_HEADER),
Paragraph("Key Agents", TABLE_HEADER),
Paragraph("Route", TABLE_HEADER)],
[Paragraph("<b>Polyenes</b>", TABLE_CELL),
Paragraph("Bind ergosterol → membrane pores → leakage & cell death", TABLE_CELL),
Paragraph("Amphotericin B, Nystatin", TABLE_CELL),
Paragraph("IV / Topical", TABLE_CELL_C)],
[Paragraph("<b>Azoles</b>\nImidazoles", TABLE_CELL),
Paragraph("Inhibit CYP450 14α-lanosterol demethylase → ↓ ergosterol synthesis", TABLE_CELL),
Paragraph("Ketoconazole, Clotrimazole, Miconazole", TABLE_CELL),
Paragraph("Oral / Topical", TABLE_CELL_C)],
[Paragraph("<b>Azoles</b>\nTriazoles", TABLE_CELL),
Paragraph("Same as imidazoles but more selective for fungal CYP → ↓ ADRs & drug interactions", TABLE_CELL),
Paragraph("Fluconazole, Itraconazole, Voriconazole, Posaconazole, Isavuconazole", TABLE_CELL),
Paragraph("Oral / IV", TABLE_CELL_C)],
[Paragraph("<b>Echinocandins</b>", TABLE_CELL),
Paragraph("Inhibit β-(1,3)-D-glucan synthase → disrupts fungal cell wall", TABLE_CELL),
Paragraph("Caspofungin, Micafungin, Anidulafungin", TABLE_CELL),
Paragraph("IV only", TABLE_CELL_C)],
[Paragraph("<b>Allylamines</b>", TABLE_CELL),
Paragraph("Inhibit squalene epoxidase → ↓ ergosterol, ↑ toxic squalene", TABLE_CELL),
Paragraph("Terbinafine, Naftifine", TABLE_CELL),
Paragraph("Oral / Topical", TABLE_CELL_C)],
[Paragraph("<b>Miscellaneous</b>", TABLE_CELL),
Paragraph("Inhibits DNA/RNA synthesis (5-FC); disrupts microtubules (Griseofulvin)", TABLE_CELL),
Paragraph("Flucytosine (5-FC), Griseofulvin", TABLE_CELL),
Paragraph("Oral", TABLE_CELL_C)],
]
class_table = Table(class_data, colWidths=[3*cm, 5.5*cm, 5.5*cm, 3*cm])
class_table.setStyle(TableStyle([
("BACKGROUND", (0,0), (-1,0), NAVY),
("BACKGROUND", (0,1), (-1,1), LTBLUE),
("BACKGROUND", (0,2), (-1,2), colors.white),
("BACKGROUND", (0,3), (-1,3), LTBLUE),
("BACKGROUND", (0,4), (-1,4), colors.white),
("BACKGROUND", (0,5), (-1,5), LTBLUE),
("BACKGROUND", (0,6), (-1,6), colors.white),
("GRID", (0,0), (-1,-1), 0.5, LGRAY),
("VALIGN", (0,0), (-1,-1), "TOP"),
("TOPPADDING", (0,0), (-1,-1), 6),
("BOTTOMPADDING", (0,0), (-1,-1), 6),
("LEFTPADDING", (0,0), (-1,-1), 6),
("FONTSIZE", (0,0), (-1,-1), 9),
]))
story.append(class_table)
story.append(sp(8))
# brief notes on each class
story.append(h2_block("2a. Polyenes"))
story.append(bullet("Act by binding to ergosterol in the fungal cell membrane, forming transmembrane pores."))
story.append(bullet("Selective toxicity: ergosterol (fungi) >> cholesterol (mammals)."))
story.append(bullet("Amphotericin B — gold standard for systemic use; Nystatin — topical only (too toxic systemically)."))
story.append(sp(4))
story.append(h2_block("2b. Azoles"))
story.append(bullet("Fungistatic (usually); block ergosterol synthesis via inhibition of CYP450 14α-lanosterol demethylase."))
story.append(bullet("<b>Imidazoles</b> (ketoconazole, miconazole, clotrimazole): less selective, more drug interactions."))
story.append(bullet("<b>Triazoles</b> (fluconazole, itraconazole, voriconazole, posaconazole, isavuconazole): greater selectivity for fungal CYP, broader spectrum."))
story.append(bullet("Voriconazole — drug of choice for invasive aspergillosis."))
story.append(bullet("Posaconazole / Isavuconazole — also active against Mucorales (zygomycosis)."))
story.append(sp(4))
story.append(h2_block("2c. Echinocandins"))
story.append(bullet("Fungicidal against Candida; fungistatic against Aspergillus."))
story.append(bullet("No activity against Cryptococcus neoformans, Mucorales, or endemic dimorphic fungi."))
story.append(bullet("IV only; minimal toxicity; few drug interactions."))
story.append(bullet("Caspofungin (loading 70 mg → 50 mg/day), Micafungin (100 mg/day), Anidulafungin (200 mg loading → 100 mg/day)."))
story.append(sp(4))
story.append(h2_block("2d. Allylamines"))
story.append(bullet("Terbinafine: oral — first-line for onychomycosis (dermatophytes); fungicidal."))
story.append(bullet("Inhibits squalene epoxidase (not CYP450) → no significant P450-drug interactions."))
story.append(sp(4))
story.append(h2_block("2e. Miscellaneous"))
story.append(bullet("<b>Flucytosine (5-FC)</b>: converted to 5-FU inside fungal cells → inhibits DNA/RNA synthesis; used only in combination (to prevent rapid resistance); active against Candida and Cryptococcus."))
story.append(bullet("<b>Griseofulvin</b>: disrupts microtubule polymerisation; deposits in keratin; used for dermatophytoses of skin/hair/nails; largely replaced by terbinafine and itraconazole."))
story.append(sp(12))
# ══════════════════════════════════════════════════════════════════════════
# SECTION 3 – AMPHOTERICIN B IN DETAIL
# ══════════════════════════════════════════════════════════════════════════
story.append(h1_block("3. AMPHOTERICIN B — DETAILED PHARMACOLOGY"))
story.append(sp(6))
story.append(h2_block("3a. Source & Chemistry"))
story.append(Paragraph(
"Amphotericin B is a <b>polyene macrolide antifungal antibiotic</b> produced by "
"<i>Streptomyces nodosus</i>. It is a <b>heptaene macrolide</b>, containing "
"seven conjugated trans-double bonds and a 3-amino-3,6-dideoxymannose "
"(mycosamine) connected through a glycosidic bond. Its <b>amphoteric</b> properties "
"(carboxyl group + primary amino group) confer aqueous solubility only at extremes "
"of pH. Conventional formulation: colloidal suspension with sodium deoxycholate "
"(Fungizone) for IV use.",
BODY))
story.append(sp(4))
story.append(h2_block("3b. Mechanism of Action"))
story.append(Paragraph(
"Amphotericin B acts by <b>binding to ergosterol</b> in the fungal cell membrane. "
"This binding causes formation of <b>transmembrane pores (ion channels)</b>, "
"resulting in loss of cytoplasmic contents (K⁺, H⁺, amino acids), "
"collapse of the electrochemical gradient, and ultimately <b>cell death</b> (fungicidal).",
BODY))
story.append(sp(2))
story.append(bullet("Selective toxicity: Much greater affinity for ergosterol (fungi) than cholesterol (mammalian cells)."))
story.append(bullet("Also has immunostimulatory properties: stimulates macrophages to produce TNF-α and IL-1."))
story.append(sp(4))
story.append(h2_block("3c. Spectrum of Activity"))
act_data = [
[Paragraph("Susceptible Organisms", TABLE_HEADER), Paragraph("Resistant / Intrinsically Resistant", TABLE_HEADER)],
[Paragraph("Candida spp. (most), Aspergillus spp.", TABLE_CELL), Paragraph("Candida lusitaniae", TABLE_CELL)],
[Paragraph("Cryptococcus neoformans", TABLE_CELL), Paragraph("Candida guilliermondii (variable)", TABLE_CELL)],
[Paragraph("Mucorales / Zygomycetes (Rhizopus, Mucor)", TABLE_CELL), Paragraph("Pseudallescheria boydii (S. apiospermum)", TABLE_CELL)],
[Paragraph("Histoplasma, Blastomyces, Coccidioides, Sporothrix", TABLE_CELL), Paragraph("Trichosporon (variable)", TABLE_CELL)],
[Paragraph("Paracoccidioides, Penicillium, Fusarium (partial)", TABLE_CELL), Paragraph("Dermatophytes — NOT susceptible", TABLE_CELL)],
]
act_table = Table(act_data, colWidths=[8.5*cm, 8.5*cm])
act_table.setStyle(TableStyle([
("BACKGROUND", (0,0), (-1,0), TEAL),
("GRID", (0,0), (-1,-1), 0.5, LGRAY),
("VALIGN", (0,0), (-1,-1), "TOP"),
("TOPPADDING", (0,0), (-1,-1), 5),
("BOTTOMPADDING", (0,0), (-1,-1), 5),
("LEFTPADDING", (0,0), (-1,-1), 6),
("ROWBACKGROUNDS",(0,1), (-1,-1), [LTBLUE, WHITE]),
]))
story.append(act_table)
story.append(sp(6))
story.append(h2_block("3d. Pharmacokinetics"))
pk_data = [
[Paragraph("Parameter", TABLE_HEADER), Paragraph("Details", TABLE_HEADER)],
[Paragraph("Absorption", TABLE_CELL), Paragraph("Not absorbed orally; IV only for systemic use", TABLE_CELL)],
[Paragraph("Distribution", TABLE_CELL), Paragraph("Vd very large; penetrates most tissues including pleura, peritoneum, joints; POOR CNS penetration (10% of serum); binds to cholesterol in host membranes", TABLE_CELL)],
[Paragraph("Protein Binding", TABLE_CELL), Paragraph(">90% bound to serum proteins", TABLE_CELL)],
[Paragraph("Blood Levels", TABLE_CELL), Paragraph("0.6 mg/kg/day IV → average blood levels 0.3–1 mcg/mL", TABLE_CELL)],
[Paragraph("Metabolism", TABLE_CELL), Paragraph("Mostly metabolised; very slow hepatic metabolism", TABLE_CELL)],
[Paragraph("Excretion", TABLE_CELL), Paragraph("Slow biliary and renal excretion; t½ ≈ 15 days; detectable in urine for 7 weeks after stopping", TABLE_CELL)],
[Paragraph("Dose adjustment", TABLE_CELL), Paragraph("Not required in renal failure (conventional formulation); however, nephrotoxicity mandates careful monitoring", TABLE_CELL)],
]
pk_table = Table(pk_data, colWidths=[3.5*cm, 13.5*cm])
pk_table.setStyle(TableStyle([
("BACKGROUND", (0,0), (-1,0), TEAL),
("GRID", (0,0), (-1,-1), 0.5, LGRAY),
("VALIGN", (0,0), (-1,-1), "TOP"),
("TOPPADDING", (0,0), (-1,-1), 5),
("BOTTOMPADDING", (0,0), (-1,-1), 5),
("LEFTPADDING", (0,0), (-1,-1), 6),
("ROWBACKGROUNDS",(0,1), (-1,-1), [colors.white, LTBLUE]),
]))
story.append(pk_table)
story.append(sp(6))
story.append(h2_block("3e. Lipid Formulations"))
story.append(Paragraph(
"Conventional amphotericin B is highly nephrotoxic, limiting its dose. "
"<b>Lipid formulations</b> package the drug in lipid delivery vehicles; amphotericin "
"binds lipids with affinity between that for ergosterol (high) and cholesterol (lower), "
"thus reducing nonspecific binding to mammalian membranes and allowing higher effective doses.",
BODY))
story.append(sp(4))
lipid_data = [
[Paragraph("Preparation", TABLE_HEADER),
Paragraph("Physical Form", TABLE_HEADER),
Paragraph("Dose (mg/kg/day)", TABLE_HEADER),
Paragraph("Nephrotoxicity", TABLE_HEADER),
Paragraph("Infusional Toxicity", TABLE_HEADER)],
[Paragraph("Fungizone (conventional)", TABLE_CELL),
Paragraph("Micelles with deoxycholate", TABLE_CELL),
Paragraph("0.5–1", TABLE_CELL_C),
Paragraph("High +++", TABLE_CELL_C),
Paragraph("High +++", TABLE_CELL_C)],
[Paragraph("AmBisome (L-AMB)", TABLE_CELL),
Paragraph("Liposomal spheres", TABLE_CELL),
Paragraph("3–5", TABLE_CELL_C),
Paragraph("↓ Low", TABLE_CELL_C),
Paragraph("↓ Low", TABLE_CELL_C)],
[Paragraph("Amphocil / ABCD", TABLE_CELL),
Paragraph("Colloidal dispersion (disks)", TABLE_CELL),
Paragraph("3–4", TABLE_CELL_C),
Paragraph("↓ Low", TABLE_CELL_C),
Paragraph("↑ Higher", TABLE_CELL_C)],
[Paragraph("Abelcet / ABLC", TABLE_CELL),
Paragraph("Lipid complex (ribbons)", TABLE_CELL),
Paragraph("5", TABLE_CELL_C),
Paragraph("↓ Low", TABLE_CELL_C),
Paragraph("↓ Low", TABLE_CELL_C)],
]
lipid_table = Table(lipid_data, colWidths=[3.5*cm, 4*cm, 3*cm, 3.25*cm, 3.25*cm])
lipid_table.setStyle(TableStyle([
("BACKGROUND", (0,0), (-1,0), NAVY),
("GRID", (0,0), (-1,-1), 0.5, LGRAY),
("VALIGN", (0,0), (-1,-1), "TOP"),
("TOPPADDING", (0,0), (-1,-1), 5),
("BOTTOMPADDING", (0,0), (-1,-1), 5),
("LEFTPADDING", (0,0), (-1,-1), 5),
("ROWBACKGROUNDS",(0,1), (-1,-1), [WHITE, LTBLUE]),
]))
story.append(lipid_table)
story.append(sp(4))
story.append(Paragraph(
"<i>L-AMB (AmBisome) is preferred in CNS fungal infections, pre-existing renal impairment, "
"and in patients with significant infusion-related reactions to conventional amphotericin B. "
"No trials directly compare lipid formulations with each other.</i>", NOTE))
story.append(sp(6))
story.append(h2_block("3f. Adverse Effects"))
story.append(Paragraph(
"<b>Amphotericin B has two main categories of toxicity: infusion-related (acute) "
"and dose-dependent (cumulative/chronic).</b>", BODY))
story.append(sp(3))
story.append(Paragraph("<b>A. Infusion-related reactions (acute, within 1–3 hours):</b>", H3))
story.append(bullet("Fever, rigors, chills, headache, nausea, vomiting"))
story.append(bullet("Hypotension, bronchospasm (anaphylactoid reaction)"))
story.append(bullet("<b>Management:</b> Premedicate with paracetamol, antihistamine (diphenhydramine), hydrocortisone; slow infusion rate; meperidine (pethidine) for rigors"))
story.append(sp(4))
story.append(Paragraph("<b>B. Dose-dependent / cumulative toxicities:</b>", H3))
story.append(bullet("<b>Nephrotoxicity</b> (most important): renal tubular acidosis, loss of K⁺ and Mg²⁺ (hypokalaemia, hypomagnesaemia), reduced GFR, azotaemia. Occurs in up to 80% of patients. Reversible with adequate hydration. Rarely permanent if cumulative dose <4 g."))
story.append(bullet("<b>Normochromic normocytic anaemia</b>: due to reduced erythropoietin production"))
story.append(bullet("<b>Thrombophlebitis</b>: at IV site"))
story.append(bullet("<b>Hypokalaemia and hypomagnesaemia</b>: require regular monitoring and replacement"))
story.append(bullet("Rarely: hepatotoxicity, arrhythmias (with rapid infusion)"))
story.append(sp(4))
story.append(gold_box(
"<b>Prevention of nephrotoxicity:</b> Normal saline loading (500 mL NS before each dose), "
"avoid concomitant nephrotoxic drugs (aminoglycosides, NSAIDs, cisplatin), monitor renal "
"function and electrolytes twice weekly."
))
story.append(sp(6))
story.append(h2_block("3g. Drug Interactions"))
story.append(bullet("Aminoglycosides, cyclosporin, cisplatin: additive nephrotoxicity"))
story.append(bullet("Corticosteroids: worsen hypokalaemia → risk of cardiac arrhythmia"))
story.append(bullet("Flucytosine (5-FC): synergistic (used in combination for cryptococcal meningitis)"))
story.append(bullet("Azoles (fluconazole, itraconazole): Amphotericin B may antagonise azoles by reducing ergosterol (the target for azoles) — clinical significance debated"))
story.append(sp(4))
story.append(h2_block("3h. Clinical Indications"))
ind_data = [
[Paragraph("Indication", TABLE_HEADER), Paragraph("Notes", TABLE_HEADER)],
[Paragraph("Invasive Aspergillosis", TABLE_CELL), Paragraph("Now superseded by voriconazole as first-line; AmB used if voriconazole resistant/intolerant", TABLE_CELL)],
[Paragraph("Mucormycosis / Zygomycosis", TABLE_CELL), Paragraph("Drug of choice (L-AMB preferred); voriconazole NOT active", TABLE_CELL)],
[Paragraph("Cryptococcal Meningitis", TABLE_CELL), Paragraph("L-AMB + flucytosine induction for 2 weeks, then fluconazole consolidation", TABLE_CELL)],
[Paragraph("Candidaemia / Invasive Candidiasis", TABLE_CELL), Paragraph("Echinocandins now preferred; AmB used in resistance or unavailability", TABLE_CELL)],
[Paragraph("Endemic Mycoses (severe)", TABLE_CELL), Paragraph("Histoplasmosis, coccidioidomycosis, blastomycosis — severe/CNS cases", TABLE_CELL)],
[Paragraph("Acute Invasive Fungal Sinusitis (ENT)", TABLE_CELL), Paragraph("L-AMB IV is cornerstone of medical management; combined with surgical debridement", TABLE_CELL)],
[Paragraph("Intrathecal / Intraventricular", TABLE_CELL), Paragraph("Fungal meningitis unresponsive to IV; specialist use", TABLE_CELL)],
]
ind_table = Table(ind_data, colWidths=[5*cm, 12*cm])
ind_table.setStyle(TableStyle([
("BACKGROUND", (0,0), (-1,0), TEAL),
("GRID", (0,0), (-1,-1), 0.5, LGRAY),
("VALIGN", (0,0), (-1,-1), "TOP"),
("TOPPADDING", (0,0), (-1,-1), 5),
("BOTTOMPADDING", (0,0), (-1,-1), 5),
("LEFTPADDING", (0,0), (-1,-1), 6),
("ROWBACKGROUNDS",(0,1), (-1,-1), [WHITE, LTBLUE]),
]))
story.append(ind_table)
story.append(sp(12))
# ══════════════════════════════════════════════════════════════════════════
# SECTION 4 – ROLE OF ANTIFUNGALS IN ENT
# ══════════════════════════════════════════════════════════════════════════
story.append(PageBreak())
story.append(h1_block("4. ROLE OF ANTIFUNGALS IN ENT — DETAILED"))
story.append(sp(6))
story.append(Paragraph(
"Fungal infections in ENT practice are increasingly recognised, particularly in "
"immunocompromised patients. Management generally involves a combination of "
"<b>surgical debridement</b> and <b>systemic antifungal therapy</b>. "
"The following classification is based on <i>K.J. Lee's Essential Otolaryngology</i>:",
BODY))
story.append(sp(8))
# ── 4A: Otomycosis ────────────────────────────────────────────────────────
story.append(h2_block("4A. OTOMYCOSIS (Fungal Otitis Externa)"))
story.append(sp(4))
story.append(Paragraph("<b>Definition & Epidemiology:</b>", H3))
story.append(Paragraph(
"Fungal infection of the external auditory canal (EAC), most commonly caused by "
"<i>Aspergillus niger</i> (most common) and <i>Candida</i> spp. Occurs in hot, "
"humid climates; predisposed by water exposure, trauma, hearing aids, and prior "
"antibiotic ear drops.",
BODY))
story.append(sp(3))
story.append(Paragraph("<b>Clinical Features:</b>", H3))
story.append(bullet("Intense pruritus (more prominent than in bacterial otitis externa)"))
story.append(bullet("Scanty ear discharge — black (Aspergillus niger), white/creamy (Candida)"))
story.append(bullet("Blocked sensation / hearing loss"))
story.append(bullet("On otoscopy: fungal debris with hyphal elements; EAC oedema"))
story.append(sp(3))
story.append(Paragraph("<b>Treatment (Antifungal Role):</b>", H3))
story.append(bullet("<b>Step 1 — Aural toilet:</b> Thorough debridement and microsuction of fungal debris under microscopy. This is ESSENTIAL and forms the cornerstone of treatment."))
story.append(bullet("<b>Step 2 — Topical antifungals:</b>"))
story.append(bullet("Clotrimazole 1% solution (ear drops) — first-line; broad-spectrum", level=2))
story.append(bullet("Nystatin drops or cream — for Candida-predominant disease", level=2))
story.append(bullet("Vioform (clioquinol) + clotrimazole combination drops — used in recalcitrant cases", level=2))
story.append(bullet("Boric acid 2% in alcohol — antifungal and acidifying; useful in chronic/recurrent cases", level=2))
story.append(bullet("<b>Step 3 — Systemic antifungals:</b> Required only in immunocompromised patients, invasive disease, or failures. Oral itraconazole or fluconazole used."))
story.append(bullet("Keep ear dry; avoid trauma; treat predisposing factors"))
story.append(sp(8))
# ── 4B: Fungal Rhinosinusitis ─────────────────────────────────────────────
story.append(h2_block("4B. FUNGAL RHINOSINUSITIS (FRS)"))
story.append(sp(4))
story.append(Paragraph(
"Fungal rhinosinusitis is classified into <b>noninvasive</b> and <b>invasive</b> forms, "
"each with distinct pathophysiology, patient populations, and antifungal requirements.",
BODY))
story.append(sp(5))
# overview table
frs_data = [
[Paragraph("Type", TABLE_HEADER),
Paragraph("Host Immunity", TABLE_HEADER),
Paragraph("Causative Fungi", TABLE_HEADER),
Paragraph("Antifungals Needed?", TABLE_HEADER)],
[Paragraph("Fungal Ball (Mycetoma)", TABLE_CELL),
Paragraph("Immunocompetent", TABLE_CELL),
Paragraph("Aspergillus fumigatus / flavus", TABLE_CELL),
Paragraph("NO — surgery alone", TABLE_CELL_C)],
[Paragraph("Allergic Fungal Rhinosinusitis (AFRS)", TABLE_CELL),
Paragraph("Immunocompetent (atopic)", TABLE_CELL),
Paragraph("Dematiaceous fungi: Bipolaris, Curvularia, Alternaria", TABLE_CELL),
Paragraph("Adjunct only (limited benefit)", TABLE_CELL_C)],
[Paragraph("Acute Invasive FRS (AIFS)", TABLE_CELL),
Paragraph("Severely immunocompromised (ANC <500, DKA)", TABLE_CELL),
Paragraph("Mucorales / Aspergillus", TABLE_CELL),
Paragraph("YES — IV AmB essential", TABLE_CELL_C)],
[Paragraph("Chronic Invasive FRS", TABLE_CELL),
Paragraph("Mildly immunocompromised / diabetic", TABLE_CELL),
Paragraph("Aspergillus spp., dematiaceous molds", TABLE_CELL),
Paragraph("YES — prolonged antifungal", TABLE_CELL_C)],
[Paragraph("Granulomatous Invasive FRS", TABLE_CELL),
Paragraph("Immunocompetent (endemic regions)", TABLE_CELL),
Paragraph("Aspergillus flavus, A. fumigatus", TABLE_CELL),
Paragraph("YES — antifungal + surgery", TABLE_CELL_C)],
]
frs_table = Table(frs_data, colWidths=[3.5*cm, 3.5*cm, 5*cm, 5*cm])
frs_table.setStyle(TableStyle([
("BACKGROUND", (0,0), (-1,0), NAVY),
("GRID", (0,0), (-1,-1), 0.5, LGRAY),
("VALIGN", (0,0), (-1,-1), "TOP"),
("TOPPADDING", (0,0), (-1,-1), 5),
("BOTTOMPADDING", (0,0), (-1,-1), 5),
("LEFTPADDING", (0,0), (-1,-1), 5),
("ROWBACKGROUNDS",(0,1), (-1,-1), [WHITE, LTBLUE]),
]))
story.append(frs_table)
story.append(sp(8))
# ── Fungal Ball ────────────────────────────────────────────────────────────
story.append(Paragraph("<b>i. Fungal Ball (Aspergilloma / Mycetoma)</b>", H3))
story.append(Paragraph(
"Dense amalgamation of fungal hyphae in a sinus cavity — usually <b>maxillary</b> "
"(most common), then sphenoid, ethmoid, frontal. Occurs in immunocompetent patients.",
BODY))
story.append(bullet("CT: Sinus opacification with heterogeneous attenuation (hyperdense foci); bony thickening/hyperostosis"))
story.append(bullet("Treatment: <b>Endoscopic sinus surgery (ESS)</b> — complete removal of fungal debris + wide ostial opening"))
story.append(bullet("<b>Antifungals NOT required</b> postoperatively in immunocompetent hosts"))
story.append(bullet("Rare progression to invasive disease in immunocompromised — antifungals then indicated"))
story.append(sp(6))
# ── AFRS ──────────────────────────────────────────────────────────────────
story.append(Paragraph("<b>ii. Allergic Fungal Rhinosinusitis (AFRS)</b>", H3))
story.append(Paragraph(
"IgE-mediated hypersensitivity to fungal antigens (type I and III), leading to "
"eosinophilic mucin, nasal polyposis, and sinonasal expansion. "
"Dematiaceous fungi (Bipolaris, Curvularia, Alternaria) are most common causative agents.",
BODY))
story.append(bullet("Hallmark: <b>Eosinophilic (allergic) mucin</b> — thick, brown/green, contains Charcot-Leyden crystals, eosinophils, non-invasive fungal hyphae"))
story.append(bullet("CT: Bilateral (often) sinus opacification with <b>heterogeneous attenuation / dual-density secretions</b>; bone erosion (expansion)"))
story.append(bullet("MRI: T2 hypointense mucin (dehydrated, high protein); peripheral mucosal enhancement"))
story.append(sp(3))
story.append(Paragraph("<b>Treatment:</b>", H3))
story.append(bullet("Surgery: Functional endoscopic sinus surgery (FESS) — complete evacuation of mucin and polyposis; wide sinus drainage"))
story.append(bullet("Systemic corticosteroids: Perioperative prednisone 0.5 mg/kg/day (mainstay)"))
story.append(bullet("Topical nasal steroids: Long-term postoperative maintenance"))
story.append(bullet("<b>Antifungals in AFRS:</b>"))
story.append(bullet("Systemic antifungals have LIMITED proven benefit in AFRS (disease is immunologic, not invasive)", level=2))
story.append(bullet("Topical antifungals (amphotericin B nasal irrigation) have been investigated — modest benefit in some studies", level=2))
story.append(bullet("Itraconazole orally — may reduce recurrence in some patients; not standard of care", level=2))
story.append(bullet("High recurrence rate; antifungals alone are insufficient; immunotherapy with fungal antigens used adjunctively"))
story.append(sp(6))
# ── AIFS ──────────────────────────────────────────────────────────────────
story.append(Paragraph("<b>iii. Acute Invasive Fungal Sinusitis (AIFS) — CRITICAL</b>", H3))
story.append(gold_box(
"<b>Medical Emergency:</b> Acute invasive fungal sinusitis has a mortality of 50–80% "
"in untreated or delayed cases. Prompt surgical debridement + reversal of "
"immunosuppression + IV antifungal therapy is life-saving."
))
story.append(sp(4))
story.append(Paragraph("<b>Definition:</b> Angioinvasive fungal infection of the sinonasal mucosa in severely immunocompromised hosts, progressing over days.", BODY))
story.append(sp(3))
story.append(Paragraph("<b>Risk Factors:</b>", H3))
story.append(bullet("Haematological malignancies with neutropenia (ANC <500 cells/mm³) — most common"))
story.append(bullet("Diabetic ketoacidosis (DKA) — especially for mucormycosis"))
story.append(bullet("Post-transplant immunosuppression, HIV/AIDS, prolonged corticosteroid use"))
story.append(sp(3))
story.append(Paragraph("<b>Causative Organisms:</b>", H3))
story.append(bullet("Mucorales order: <i>Rhizopus, Mucor, Rhizomucor, Cunninghamella</i> — rhino-orbital-cerebral mucormycosis"))
story.append(bullet("Aspergillus fumigatus / flavus — angioinvasive aspergillosis"))
story.append(sp(3))
story.append(Paragraph("<b>Clinical Features:</b>", H3))
story.append(bullet("Fever unresponsive to antibiotics, nasal congestion, bloody discharge"))
story.append(bullet("Facial pain/numbness, periorbital oedema"))
story.append(bullet("Eschar formation on nasal mucosa, palate, or turbinates — PATHOGNOMONIC of necrosis"))
story.append(bullet("Proptosis, ophthalmoplegia, visual loss → orbital involvement"))
story.append(bullet("Cavernous sinus thrombosis, intracranial extension (very poor prognosis)"))
story.append(sp(3))
story.append(Paragraph("<b>Diagnosis:</b>", H3))
story.append(bullet("Endoscopy + biopsy: Tissue invasion with angioinvasion and necrosis — ESSENTIAL"))
story.append(bullet("CT: Unilateral mucosal thickening, bony erosion, extrasinus fat stranding"))
story.append(bullet("MRI Gd: <b>'Black turbinate sign'</b> — absence of enhancement in sinonasal mucosa on T1 post-contrast = mucosal necrosis from angioinvasion (highly suggestive of AIFS)"))
story.append(sp(3))
story.append(Paragraph("<b>Treatment — Three Pillars:</b>", H3))
story.append(bullet("<b>Pillar 1 — Surgical debridement:</b> Aggressive endoscopic surgery; open approaches (maxillectomy, orbital exenteration) for orbital/cerebral extension"))
story.append(bullet("<b>Pillar 2 — Reversal of immunosuppression:</b> Correct neutropenia (G-CSF), control DKA, reduce steroids if possible"))
story.append(bullet("<b>Pillar 3 — Prolonged IV antifungal therapy:</b>"))
story.append(sp(2))
aifs_drug = [
[Paragraph("Organism", TABLE_HEADER), Paragraph("Drug of Choice", TABLE_HEADER), Paragraph("Alternative", TABLE_HEADER)],
[Paragraph("Mucorales (Mucormycosis)", TABLE_CELL),
Paragraph("Liposomal Amphotericin B (L-AMB) 5–10 mg/kg/day", TABLE_CELL),
Paragraph("Isavuconazole or Posaconazole (stepdown/combination)", TABLE_CELL)],
[Paragraph("Aspergillus (Aspergillosis)", TABLE_CELL),
Paragraph("Voriconazole 6 mg/kg IV q12h (loading) → 4 mg/kg q12h", TABLE_CELL),
Paragraph("L-AMB 3–5 mg/kg/day; Isavuconazole; Caspofungin (combination)", TABLE_CELL)],
]
aifs_table = Table(aifs_drug, colWidths=[4*cm, 7*cm, 6*cm])
aifs_table.setStyle(TableStyle([
("BACKGROUND", (0,0), (-1,0), NAVY),
("GRID", (0,0), (-1,-1), 0.5, LGRAY),
("VALIGN", (0,0), (-1,-1), "TOP"),
("TOPPADDING", (0,0), (-1,-1), 6),
("BOTTOMPADDING", (0,0), (-1,-1), 6),
("LEFTPADDING", (0,0), (-1,-1), 6),
("ROWBACKGROUNDS",(0,1), (-1,-1), [WHITE, LTBLUE]),
]))
story.append(aifs_table)
story.append(sp(4))
story.append(Paragraph(
"<i>Duration: Continue antifungals until resolution of infection and immune reconstitution — "
"often months. Serial MRI/CT monitoring required. Surgical debridement may need to be repeated.</i>",
NOTE))
story.append(sp(6))
# ── Chronic Invasive FRS ──────────────────────────────────────────────────
story.append(Paragraph("<b>iv. Chronic Invasive Fungal Sinusitis</b>", H3))
story.append(Paragraph(
"Indolent form (>4 weeks) occurring in mildly immunocompromised or diabetic patients. "
"Caused by Aspergillus spp. and dematiaceous molds. Presents like chronic rhinosinusitis "
"with late complications (proptosis, cranial neuropathies).",
BODY))
story.append(bullet("Treatment: Same three pillars as AIFS — surgical debridement + reversal of immunosuppression + prolonged antifungal therapy"))
story.append(bullet("Voriconazole for Aspergillus; L-AMB for mucorales; long-term oral itraconazole/voriconazole for step-down"))
story.append(bullet("Long-term surveillance is mandatory"))
story.append(sp(6))
# ── Granulomatous Invasive FRS ────────────────────────────────────────────
story.append(Paragraph("<b>v. Granulomatous Invasive Fungal Sinusitis</b>", H3))
story.append(Paragraph(
"Rare; characterised by non-caseating granulomas with giant cells and dense fibrosis. "
"Reported in Sudan, India, Pakistan, Saudi Arabia. Caused by Aspergillus flavus. "
"Presents with unilateral <b>proptosis</b> — often mistaken for a tumour.",
BODY))
story.append(bullet("Treatment: Surgical debridement + antifungal therapy (voriconazole or itraconazole)"))
story.append(sp(8))
# ── 4C: Oropharyngeal & Laryngeal Candidiasis ─────────────────────────────
story.append(h2_block("4C. OROPHARYNGEAL & LARYNGEAL CANDIDIASIS"))
story.append(sp(4))
story.append(Paragraph(
"Most commonly caused by <i>Candida albicans</i>. "
"Predisposing factors: HIV/AIDS, corticosteroid inhaler use, dentures, xerostomia, "
"chemotherapy, diabetes, prolonged antibiotics.",
BODY))
story.append(bullet("<b>Oral thrush:</b> White pseudomembranous plaques — wipe off leaving erythematous base"))
story.append(bullet("<b>Laryngeal candidiasis:</b> Hoarseness, dysphagia, odynophagia; white plaques on laryngoscopy; in immunocompromised"))
story.append(sp(3))
story.append(Paragraph("<b>Treatment:</b>", H3))
story.append(bullet("Mild–moderate (immunocompetent): Topical nystatin oral suspension (swish and swallow) OR clotrimazole troches"))
story.append(bullet("Moderate–severe or immunocompromised: Systemic fluconazole 100–200 mg/day × 7–14 days (first-line)"))
story.append(bullet("Fluconazole-resistant (C. krusei, C. glabrata): Voriconazole, posaconazole, or echinocandin"))
story.append(bullet("Correct predisposing factors — rinse mouth after steroid inhaler; treat underlying immunosuppression"))
story.append(sp(8))
# ── 4D: Pharyngeal / Deep Neck Fungal Infections ──────────────────────────
story.append(h2_block("4D. DEEP-NECK & PHARYNGEAL FUNGAL INFECTIONS"))
story.append(sp(4))
story.append(Paragraph(
"Uncommon; occur in severely immunocompromised patients. May involve parapharyngeal, "
"retropharyngeal, and masticator spaces. Candida, Aspergillus, and Mucorales implicated.",
BODY))
story.append(bullet("Treatment: Systemic antifungal (based on organism) + surgical drainage where applicable"))
story.append(bullet("Amphotericin B IV for mucormycosis of deep neck spaces; voriconazole for aspergillosis"))
story.append(sp(8))
# ══════════════════════════════════════════════════════════════════════════
# SECTION 5 – SUMMARY TABLE
# ══════════════════════════════════════════════════════════════════════════
story.append(PageBreak())
story.append(h1_block("5. QUICK REVISION — HIGH-YIELD POINTS FOR PG EXAM"))
story.append(sp(6))
hiyield = [
["Drug of choice for mucormycosis (AIFS)", "Liposomal Amphotericin B (L-AMB)"],
["Drug of choice for invasive aspergillosis", "Voriconazole (primary); L-AMB (alternative)"],
["Drug NOT active against Mucorales", "Voriconazole, Echinocandins"],
["Echinocandins NOT active against", "Cryptococcus, Mucorales, endemic dimorphic fungi"],
["Antifungal required for fungal ball in immunocompetent", "NONE — surgery alone suffices"],
["Antifungal role in AFRS", "Limited; adjunct only; topical AmB irrigation investigated"],
["'Black turbinate sign' on MRI", "Acute invasive fungal sinusitis — mucosal necrosis"],
["Most common cause of otomycosis", "Aspergillus niger > Candida"],
["First-line for otomycosis (topical)", "Clotrimazole 1% ear drops + aural toilet"],
["Lipid AmB advantage over conventional", "↓ Nephrotoxicity, ↓ infusion reactions; same/better efficacy"],
["AmB + flucytosine combination used for", "Cryptococcal meningitis induction therapy"],
["Fluconazole NOT effective against", "Aspergillus, Mucorales, C. krusei (intrinsic resistance)"],
["Mechanism — Amphotericin B", "Binds ergosterol → membrane pores → cell death (fungicidal)"],
["Mechanism — Azoles", "Inhibit CYP450 14α-demethylase → ↓ ergosterol synthesis"],
["Mechanism — Echinocandins", "Inhibit β-(1,3)-D-glucan synthase → disrupts cell wall"],
["Mechanism — Terbinafine", "Inhibits squalene epoxidase → ↑ toxic squalene accumulation"],
["Mechanism — 5-FC (Flucytosine)", "Converted to 5-FU inside fungi → inhibits DNA/RNA synthesis"],
["Amphotericin B nephrotoxicity prevention", "Normal saline loading before each dose; avoid nephrotoxins"],
["AFRS characteristic pathological mucin", "Eosinophilic mucin + Charcot-Leyden crystals"],
["Most common sinus in fungal ball", "Maxillary sinus (>50%)"],
]
hy_table_data = [
[Paragraph("Key Question / Concept", TABLE_HEADER), Paragraph("Answer / Key Point", TABLE_HEADER)]
] + [
[Paragraph(r[0], TABLE_CELL), Paragraph(f"<b>{r[1]}</b>", TABLE_CELL)]
for r in hiyield
]
hy_table = Table(hy_table_data, colWidths=[8*cm, 9*cm])
hy_table.setStyle(TableStyle([
("BACKGROUND", (0,0), (-1,0), NAVY),
("GRID", (0,0), (-1,-1), 0.5, LGRAY),
("VALIGN", (0,0), (-1,-1), "TOP"),
("TOPPADDING", (0,0), (-1,-1), 5),
("BOTTOMPADDING", (0,0), (-1,-1), 5),
("LEFTPADDING", (0,0), (-1,-1), 6),
("ROWBACKGROUNDS",(0,1), (-1,-1), [WHITE, LTBLUE]),
]))
story.append(hy_table)
story.append(sp(10))
# ══════════════════════════════════════════════════════════════════════════
# SECTION 6 – REFERENCES
# ══════════════════════════════════════════════════════════════════════════
story.append(h1_block("6. REFERENCES"))
story.append(sp(5))
story.append(bullet("Katzung BG. Basic and Clinical Pharmacology, 16th ed. Chapter 48: Antifungal Agents."))
story.append(bullet("Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed. Chapter 61."))
story.append(bullet("K.J. Lee's Essential Otolaryngology, 12th ed. Chapter 30: Fungal Rhinosinusitis."))
story.append(bullet("Goldman-Cecil Medicine International Edition. Antifungal Agents & Antifungal Treatment."))
story.append(bullet("Jawetz, Melnick & Adelberg's Medical Microbiology, 28th ed. Antifungal Chemotherapies."))
story.append(sp(10))
# ── footer note ────────────────────────────────────────────────────────────
story.append(hr())
story.append(Paragraph(
"<i>Prepared by Orris — AI Medical Notes | For ENT PG Entrance Examination Preparation | May 2026</i>",
NOTE))
doc.build(story)
print(f"PDF saved: {OUTPUT}")
build()
cd /home/daytona/workspace/antifungals-ent && python generate_pdf.py 2>&1
ls -lh /home/daytona/workspace/antifungals-ent/Antifungals_ENT_PG_Essay.pdf
Antifungals ENT PG Essay
PDF Document · PDF
| Class | Mechanism | Key Agents |
|---|---|---|
| Polyenes | Bind ergosterol → membrane pores | Amphotericin B, Nystatin |
| Azoles (Imidazoles) | CYP450 14α-demethylase inhibition | Ketoconazole, Clotrimazole |
| Azoles (Triazoles) | Same, more selective | Fluconazole, Itraconazole, Voriconazole, Posaconazole |
| Echinocandins | β-(1,3)-D-glucan synthase inhibition | Caspofungin, Micafungin, Anidulafungin |
| Allylamines | Squalene epoxidase inhibition | Terbinafine |
| Miscellaneous | DNA/RNA inhibition, microtubule disruption | 5-FC (Flucytosine), Griseofulvin |